Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiofollicular Lymph Node Hyperplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07085039
What this trial is testing

Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman's Disease (CD)Idiopathic Multicentric Castleman's Disease
University of Pennsylvania 14
Not applicableStudy completedNCT03169595
What this trial is testing

Epithelioid Hemangioma of Bone And Soft Tissue

Who this might be right for
Epithelioid Hemangioma of BoneEpithelioid Hemangioma
Istituto Ortopedico Rizzoli 70
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Early research (Phase 1)Study completedNCT00412321
What this trial is testing

A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

Who this might be right for
Lymphoma, Non-HodgkinMultiple MyelomaGiant Lymph Node Hyperplasia
Centocor, Inc. 67
Testing effectiveness (Phase 2)Study completedNCT04585893
What this trial is testing

Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi

Who this might be right for
Multicentric Castleman Disease
UNC Lineberger Comprehensive Cancer Center 15
Early research (Phase 1)Ended earlyNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 154
Testing effectiveness (Phase 2)Active Not RecruitingNCT05345522
What this trial is testing

Anti-IL-6R mAb Injection in Patients With iMCD

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Beijing VDJBio Co., LTD. 25
Not applicableActive Not RecruitingNCT04742387
What this trial is testing

Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis

Who this might be right for
Kaposi SarcomaKSHV Associated Multicentric Castleman DiseasePrimary Effusion Lymphoma+1 more
National Cancer Institute (NCI) 40
Not applicableTemporarily pausedNCT05028621
What this trial is testing

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Who this might be right for
Castleman's Disease (CD)Langerhans Cell Histiocytosis (LCH)Non-Langerhans-Cell Histiocytosis
Case Comprehensive Cancer Center 135
Not applicableStudy completedNCT00695422
What this trial is testing

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

Who this might be right for
Aids-related MalignanciesLymphomaPrecancerous Condition+1 more
AIDS Malignancy Consortium 47
Testing effectiveness (Phase 2)Looking for participantsNCT05907759
What this trial is testing

Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease

Who this might be right for
Lymphoma, Primary Effusion
National Cancer Institute (NCI) 28
Early research (Phase 1)Active Not RecruitingNCT02659930
What this trial is testing

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT01024036
What this trial is testing

Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease

Who this might be right for
Multicentric Castleman's Disease
Janssen Research & Development, LLC 79
Not applicableLooking for participantsNCT07793006
What this trial is testing

New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease

Who this might be right for
HIVKaposi Sarcoma Herpesvirus -Associated Multicentric Castleman DiseaseHodgkin Lymphoma+3 more
Indiana University 500
Not applicableStudy completedNCT02853968
What this trial is testing

Unlock the Cell: Castleman's Disease Flow Cytometry Study

Who this might be right for
Castleman DiseaseAngiofollicular Lymphoid HyperplasiaGLNH+4 more
University of Pennsylvania 130
Testing effectiveness (Phase 2)UnknownNCT04743687
What this trial is testing

Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)UnknownNCT03982771
What this trial is testing

BCD Regimen in Newly Diagnosed Idiopathic Multicentric Castleman's Disease (iMCD)

Who this might be right for
Idiopathic Multicentric Castleman's Disease
Peking Union Medical College Hospital 30
Early research (Phase 1)Ended earlyNCT03864419
What this trial is testing

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Who this might be right for
Burkitt LymphomaKSHV-associated Multicentric Castleman DiseaseDiffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer Center 18
Early research (Phase 1)UnknownNCT00891280
What this trial is testing

Dose-escalation Study of Oral CX-4945

Who this might be right for
Advanced Solid TumorsBreast CancerInflammatory Breast Cancer+2 more
Cylene Pharmaceuticals 55
Post-approval studies (Phase 4)WithdrawnNCT00361933
What this trial is testing

Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease

Who this might be right for
Giant Lymph Node Hyperplasia
University of Washington
Next Page